A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)
Clinical trial NCT03145909 · TERMINATED
Trial details
- NCT number
- NCT03145909
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-03
- Primary completion
- 2018-11-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.